Slide 1: FY2017 Revenue Conference Call
me cegedim FY2017 Revenue Conference Call 29 January 2018
Slide 2: Caution Concerning Forward-Looking Statements
Caution Concerning Forward-Looking Statements This presentation contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on expectations and assumptions that we believe to be reasonable when made, but that
Slide 3: Key Take Away
FY2017 BUSINESS OVERVIEW * Business model transformation is having a positive effect * From a business model transformation to an integrated connected, full service cloud-digital suite * Cegelease business sold FINANCE * FY 2017 revenue €457.4m up 6.6% reported up 5.9% L-f-1 * Like-for-like growth a
Slide 4: Agenda
Agenda Strategy Finance Appendices 4 © cegedim 2018
Slide 5: Strategy: From a Business Model Transformation Plan to an Integrated Connected, Full-Service Cloud Digital suite
From a Business Model Strategy Transformation Plan to an Integrated Connected, Full-Service Cloud Digital suite
Slide 6: Business Model Transformation Plan
Business Model Transformation Plan 6
Slide 7: Cegelease Disposal Update
Cegelease Disposal Update 7 © cegedim 2018
Slide 8: Connected Ecosystem is the Future of Healthcare
Connected Ecosystem is the Future of Healthcare All these forces are pointing toward an ever-more COMPLEX and INTERCONNECTED health and care environment Consumer and clinician expectations are also changing at a rapid pace alongside technology change, CREATING A PERFECT STORM OF HEALTHCARE TRANSFORM
Slide 9: Cegedim: Unique Digital Connected Healthcare Ecosystem
Cegedim: Unique Digital Connected Healthcare Ecosystem 9 © cegedim 2018
Slide 10: Cegedim FY 2017 Revenue Highlights
Cegedim FY 2017 Revenue Finance Highlights IFRS 5 Cegedim announced on December 14, 2017 that it had signed a contract for the definitive sale of its Cegelease and Eurofarmat businesses. As a result, the consolidated 2017 financial statements are presented according to IFRS 5, “Non-current assets he
Slide 11: 2017 Revenue from Continuing Activities Overview
2017 Revenue from Continuing Activities Overview 11 © cegedim 2018
Slide 12: 2017 Quarterly Organic Revenue Growth
2017 Quaterly Organic Revenue Growth 12 © cegedim 2018
Slide 13: Health Insurance, HR & e-services Division
Health Insurance, HR & e-services Division • The increase was chiefly attributable to double-digit growth: In point-of-sale advertising in pharmacies, which now has a stronger digital offering since acquiring Futuramedia; At Cegedim SRH (SaaS platform for HR management); In BPO activities for health
Slide 14: Healthcare Professionals Division
Healthcare Professionals Division • Growth over the full year was fuelled by stronger sales in computerization for: Doctors in Belgium, France and the US; Doctors in the UK in Q4, following declines in the first three quarters. Full SaaS version will not be on the market until June; French pharmacis
Slide 15: 2017 BPO Revenue
coe 2017 BPO Revenue Revenue FY2017 BPO INSURANCE
Slide 16: Significant increase in Headcount
Significant increase in Headcount Between Jan. 2015 and Jan. 2017 16
Slide 17: FY 2017 Cegedim Outlook
FY 2017 Cegedim Outlook Finance as of January 29, 2018
Slide 18: Potential Impact of Brexit
Potential Impact of Brexit • Cegedim operates in the UK in local currency, as it does in all the countries where it operates • No major European health program is at work in the UK Thus, the impact on the consolidated Group EBIT margin should be marginal 10.9% UK revenue as a share of 2017 consoli
Slide 19: FY 2017 Outlook
FY 2017 Outlook • The Business Model Transformation is well under way • Growth momentum and improving profitability is expected to continue • We expect to see the full impact of the Business Model Transformation in 2018 • The Group is revising significantly upwards its outlook for 2017 EBITDA • The
Slide 20: FY 2017 Revenue Appendices
FY 2017 Revenue om) ® 2 ao) < ® ro% 2 <x
Slide 21: Application of IFRS 5
Application of IFRS 5 On December 14, 2017, Cegedim announced that it had signed a contract for the definitive sale of its Cegelease and Eurofarmat businesses. The deal is expected to take effect following the release of this document, in the first quarter of 2018. As a result, the consolidated 2017
Slide 22: Shareholder Structure as of Dec. 2017
Shareholder Structure as of Dec. 2017 22 © cegedim 2018
Slide 23: 2018 Financial Calendar
2018 Financial Calendar 23 © cegedim 2018
Slide 24: Follow us
Follow us IR APP WEB SITE WEBCAST SOCIAL NETWORK 24 © cegedim 2018
Slide 25: Jan Eryk Umiastowski
Jan Eryk Umiastowski Chief Investment Officer – Head of Investor Relations janeryk.umiastowski@cegedim.com Tel: 00 33 1 49 09 33 36 – Mob: 00 33 6 73 25 96 34 Design: Group Communication Service